Related Experiment Videos

Hypertension-Mediated Organ Damage: Pathophysiological Mechanisms, Clinical Consequences, and Implications for Early

Ali Hussein Choker1

  • 1Independent Researcher (Cardiovascular Medicine), New Vision University School of Medicine, Tbilisi, Georgia.

Clinical and Experimental Pharmacology & Physiology
|June 19, 2026
PubMed

Insights

Hypertension-mediated organ damage (HMOD) is a systemic injury linking high blood pressure to adverse events. Early detection and organ-protective treatments are key to improving outcomes beyond blood pressure control alone.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Hypertension-mediated organ damage (HMOD) is a critical link between elevated blood pressure and adverse cardiovascular and renal events.
  • HMOD is a systemic, cumulative process involving structural and functional injury to the heart, brain, kidneys, and vasculature, often initially subclinical.
  • Key manifestations like left ventricular hypertrophy and cerebral small vessel disease are dynamic and potentially modifiable.

Purpose of the Study:

  • To synthesize current evidence on the pathogenesis and clinical sequelae of HMOD.
  • To summarize contemporary detection and risk stratification approaches based on 2023 ESH and 2024 ESC guidelines.
  • To review evidence for organ protection as a therapeutic objective and analyze unresolved issues in HMOD management.

Main Methods:

  • Narrative review of current evidence.
  • Focus on the interplay of hemodynamic load, endothelial dysfunction, oxidative stress, neurohormonal activation, inflammation, and microvascular remodeling.
  • Integration of imaging and biomarker-based assessment guided by recent European hypertension and cardiology guidelines.

Main Results:

  • HMOD involves complex interactions between hemodynamic load and various pathophysiological pathways.
  • Left ventricular hypertrophy, hypertensive nephrosclerosis, cerebral small vessel disease, and arterial stiffness are key manifestations.
  • Organ protection, including regression of left ventricular mass and reduction in albuminuria, improves prognosis beyond blood pressure reduction.

Conclusions:

  • Early detection and risk stratification of HMOD are crucial for managing hypertension.
  • Organ-protective strategies are vital therapeutic objectives, offering prognostic benefits.
  • Further research is needed to clarify biomarker causality, vascular index validity, and treatment heterogeneity for optimized clinical care.

Keywords:
RAASalbuminuriaarterial stiffnessendothelial dysfunctionhaemodynamic stresshypertension‐mediated organ damagehypertensive nephrosclerosisleft ventricular hypertrophy

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...